FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pieter Meenhorst

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Physiology

Drug Interactions

Concepts & Ideas

Co-author Network

Publications

TOP 3
Paul H M Smits; Remco Bakker; Eefje Jong; Jan W Mulder; Pieter L Meenhorst; Bernhard Kleter; Leen-Jan van Doorn; Wim Quint
High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.
Kristel M L Crommentuyn; Bregt S Kappelhoff; Jan W Mulder; Albert T A Mairuhu; Eric C M van Gorp; Pieter L Meenhorst; Alwin D R Huitema; Jos H Beijnen
Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients.
Bregt S Kappelhoff; Alwin D R Huitema; Sanjay U C Sankatsing; Pieter L Meenhorst; Eric C M van Gorp; Jan W Mulder; Jan M Prins; Jos H Beijnen
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pieter Meenhorst (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Paul H M Smits; Remco Bakker; Eefje Jong; Jan W Mulder; Pieter L Meenhorst; Bernhard Kleter; Leen-Jan van Doorn; Wim Quint
High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.
Journal of clinical microbiology 2005;43(12):5936-9.
2005: Kristel M L Crommentuyn; Bregt S Kappelhoff; Jan W Mulder; Albert T A Mairuhu; Eric C M van Gorp; Pieter L Meenhorst; Alwin D R Huitema; Jos H Beijnen
Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients.
British journal of clinical pharmacology 2005;60(4):378-89.
2005: Bregt S Kappelhoff; Alwin D R Huitema; Sanjay U C Sankatsing; Pieter L Meenhorst; Eric C M van Gorp; Jan W Mulder; Jan M Prins; Jos H Beijnen
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.
British journal of clinical pharmacology 2005;60(3):276-86.
2005: Markus Joerger; Alwin D R Huitema; Pieter L Meenhorst; J H M Schellens; Jos H Beijnen
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Cancer chemotherapy and pharmacology 2005;55(5):488-96.
2005: Bregt S Kappelhoff; Alwin D R Huitema; Kristel M L Crommentuyn; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Albert T A Mairuhu; Jos H Beijnen
Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients.
British journal of clinical pharmacology 2005;59(2):174-82.
2005: Bregt S Kappelhoff; Alwin D R Huitema; Zeynep Yalvaç; Jan M Prins; Jan W Mulder; Pieter L Meenhorst; Jos H Beijnen
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
Clinical pharmacokinetics 2005;44(8):849-61.
2004: Kristel M L Crommentuyn; Jan W Mulder; Albert T A Mairuhu; Eric C M van Gorp; Pieter L Meenhorst; Alwin D R Huitema; Jos H Beijnen
The plasma and intracellular steady-state pharmacokinetics of lopinavir/ritonavir in HIV-1-infected patients.
Antiviral therapy 2004;9(5):779-85.
2004: M M R de Maat; Anthonius de Boer; Cornelis H W Koks; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Albert T A Mairuhu; Alwin D R Huitema; J H Beijnen
Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.
Journal of clinical pharmacy and therapeutics 2004;29(2):121-30.
2003: Alwin D R Huitema; Rob A J Kuiper; Pieter L Meenhorst; Jan W Mulder; Jos H Beijnen
Photophobia in a patient with high indinavir plasma concentrations.
Therapeutic drug monitoring 2003;25(6):735-7.
2003: Monique M R de Maat; Rob ter Heine; Jan W Mulder; Pieter L Meenhorst; Albert T A Mairuhu; Eric C M van Gorp; Alwin D R Huitema; Jos H Beijnen
Incidence and risk factors for nevirapine-associated rash.
European journal of clinical pharmacology 2003;59(5-6):457-62.
2003: Monique M R de Maat; Alwin D R Huitema; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Albert T A Mairuhu; Jos H Beijnen
Subtherapeutic antiretroviral plasma concentrations in routine clinical outpatient HIV care.
Therapeutic drug monitoring 2003;25(3):367-73.
2003: Monique M R de Maat; Daniël M Jonker; Cornelis H W Koks; Pieter L Meenhorst; Jan W Mulder; Teun M Post; Eric C M van Gorp; Anthonius de Boer; Jos H Beijnen
Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001.
Clinical drug investigation 2003;23(1):45-53.
2003: Monique M R de Maat; Alwin D R Huitema; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Albert T A Mairuhu; Jos H Beijnen
Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals.
Clinical drug investigation 2003;23(10):629-37.
2002: Monique M R de Maat; Alwin D R Huitema; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Jos H Beijnen
Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.
British journal of clinical pharmacology 2002;54(4):378-85.
2002: Monique M R de Maat; Ron A A Mathôt; Agnes I Veldkamp; Aldwin D R Huitma; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Hilde Carlier; Jos H Beijnen
Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;46(3):295-300.
2002: Cornelis H W Koks; Pieter L Meenhorst; A Bult; Jos H Beijnen
Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;46(2):195-201.
2002: Cornelis H W Koks; Kristel M L Crommentuyn; Ron A A Mathôt; Jan W Mulder; Pieter L Meenhorst; Jos H Beijnen
Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individuals.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;46(1):89-94.
2002: Brian S N Blank; Pieter L Meenhorst; W Pauw; Jan W Mulder; WC van Dijk; Paul H M Smits; F Roeles; Jaap Middeldorp; Joep M A Lange
Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;25(1):29-38.
2002: Servi J C Stevens; Brian S N Blank; Paul H M Smits; Pieter L Meenhorst; Jaap Middeldorp
High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.
AIDS (London, England) 2002;16(7):993-1001.
2002: Leonieke M M Wolters; Hubert G M Niesters; Bettina E Hansen; Marchina E Van Der Ende; Frank P Kroon; C Richter; Kees Brinkman; Pieter L Meenhorst; Robert A de Man
Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;24(3):173-81.
2002: Monique M R de Maat; Suzanne V Frankfort; Ron A A Mathôt; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Cornelis H W Koks; Richard Hoetelmans; Anthonius de Boer; Jos H Beijnen
Discrepancies between medical and pharmacy records for patients on anti-HIV drugs.
The Annals of pharmacotherapy 2002;36(3):410-5.
2001: Agnes I Veldkamp; Pieter L Meenhorst; Jan W Mulder; J H Beijnen
HAART, or just mini-HAART?
Journal of acquired immune deficiency syndromes (1999) 2001;28(5):495-6.
2001: Rolf P G van Heeswijk; Agnes I Veldkamp; Jan W Mulder; Pieter L Meenhorst; Joep M A Lange; Jos H Beijnen; Richard Hoetelmans
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.
Antiviral therapy 2001;6(4):201-29.
2001: Agnes I Veldkamp; Rolf P G van Heeswijk; Jan W Mulder; Pieter L Meenhorst; Richard Hoetelmans; Joep M A Lange; Jos H Beijnen
Limited sampling strategies for the estimation of the systemic exposure to the HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine.
Therapeutic drug monitoring 2001;23(6):606-11.
2001: Pythia T Nieuwkerk; Mirjam A G Sprangers; David Burger; Richard Hoetelmans; Patricia W H Hugen; Sven A Danner; Marchina E Van Der Ende; M M E Schneider; G Schrey; Pieter L Meenhorst; Herman Sprenger; Robbert H Kauffmann; Marielle Jambroes; Margaret A Chesney; Frank de Wolf; Joep M A Lange
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
Archives of internal medicine 2001;161(16):1962-8.
2001: Agnes I Veldkamp; Rolf P G van Heeswijk; Jan W Mulder; Pieter L Meenhorst; Gerrit Schreij; Siebe van der Geest; Joep M A Lange; Jos H Beijnen; Richard Hoetelmans
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals.
Journal of acquired immune deficiency syndromes (1999) 2001;27(4):344-9.
2001: Cornelis H W Koks; Kristel M L Crommentuyn; Richard Hoetelmans; David Burger; P P Koopmans; Ron A A Mathôt; Jan W Mulder; Pieter L Meenhorst; Jos H Beijnen
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals.
British journal of clinical pharmacology 2001;51(6):631-5.
2001: Rolf P G van Heeswijk; Agnes I Veldkamp; Jan W Mulder; Pieter L Meenhorst; J H Beijnen; Joep M A Lange; Richard Hoetelmans
Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapine.
Therapeutic drug monitoring 2001;23(3):255-8.
2001: David Burger; Patricia W H Hugen; Rob E Aarnoutse; Jeanne P Dieleman; J M Prins; T van der Poll; Jacob H Ten Veen; Jan W Mulder; Pieter L Meenhorst; Willem L Blok; J T van der Meer; Peter Reiss; Joep M A Lange
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy.
Journal of acquired immune deficiency syndromes (1999) 2001;26(3):218-24.
2001: Monique M R de Maat; Richard Hoetelmans; R A Math t; Eric C M van Gorp; Pieter L Meenhorst; Jan W Mulder; Jos H Beijnen
Drug interaction between St John's wort and nevirapine.
AIDS (London, England) 2001;15(3):420-1.
2000: Rolf P G van Heeswijk; Agnes I Veldkamp; Jan W Mulder; Pieter L Meenhorst; Ferdinand W N M Wit; Peter Reiss; Joep M A Lange; MO Kwakkelstein; Jos H Beijnen; Richard Hoetelmans
Nevirapine plus didanosine: once or twice daily combination?
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):93-5.
2000: Patricia W H Hugen; David Burger; M de Graaff; Hadewych J M ter Hofstede; Richard Hoetelmans; Kees Brinkman; Pieter L Meenhorst; Jan W Mulder; Peter P Koopmans; Yechiel A Hekster
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir.
Therapeutic drug monitoring 2000;22(4):437-45.
2000: Rolf P G van Heeswijk; Agnes I Veldkamp; Jan W Mulder; Pieter L Meenhorst; Joep M A Lange; Jos H Beijnen; Richard Hoetelmans
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
AIDS (London, England) 2000;14(9):F103-10.
2000: Rolf P G van Heeswijk; Agnes I Veldkamp; Jan W Mulder; Pieter L Meenhorst; Ferdinand W N M Wit; Joep M A Lange; Sven A Danner; NA Foudraine; MO Kwakkelstein; Peter Reiss; Jos H Beijnen; Richard Hoetelmans
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
AIDS (London, England) 2000;14(8):F77-82.
2000: Brian S N Blank; Pieter L Meenhorst; Jan W Mulder; Gerrit Jan Weverling; H Putter; W Pauw; WC van Dijk; P Smits; S Lie-A-Ling; P Reiss; Joep M A Lange
Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
Journal of clinical microbiology 2000;38(2):563-9.
2000: Cornelis H W Koks; Rolf P G van Heeswijk; Agnes I Veldkamp; Pieter L Meenhorst; Jan W Mulder; J T van der Meer; J H Beijnen; Richard Hoetelmans
Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir.
AIDS (London, England) 2000;14(1):89-90.
1999: Brian S N Blank; Pieter L Meenhorst; Gerrit Jan Weverling; A A Stout-Zonneveld; W Pauw; Jan W Mulder; WC van Dijk; P Smits; Joep M A Lange
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients.
AIDS (London, England) 1999;13(18):2533-9.
1999: Agnes I Veldkamp; Richard Hoetelmans; Jos H Beijnen; Jan W Mulder; Pieter L Meenhorst
Ritonavir enables combined therapy with rifampin and saquinavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(6):1586.
1999: Agnes I Veldkamp; Rolf P G van Heeswijk; Pieter L Meenhorst; Jan W Mulder; Joep M A Lange; Jos H Beijnen; Richard Hoetelmans
Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography. B, Biomedical sciences and applications 1999;734(1):55-61.
1999: Rolf P G van Heeswijk; Agnes I Veldkamp; Richard Hoetelmans; Jan W Mulder; Gerrit Schreij; A Hsu; Joep M A Lange; Jos H Beijnen; Pieter L Meenhorst
The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals.
AIDS (London, England) 1999;13(14):F95-9.
1999: Daan W Notermans; Nadine Pakker; Dörte Hamann; NA Foudraine; Robbert H Kauffmann; Pieter L Meenhorst; Jaap Goudsmit; Marijke Th L Roos; P T A Schellekens; Frank Miedema; Sven A Danner
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
The Journal of infectious diseases 1999;180(4):1050-6.
1999: Servi J C Stevens; Marcel B H J Vervoort; Adriaan J C van den Brule; Pieter L Meenhorst; Chris J L M Meijer; Jaap Middeldorp
Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR.
Journal of clinical microbiology 1999;37(9):2852-7.
1999: James W T Cohen Stuart; Rob Schuurman; David Burger; Peter P Koopmans; Herman Sprenger; Job R Juttmann; Clemens Richter; Pieter L Meenhorst; Richard Hoetelmans; Frank P Kroon; B Bravenboer; Dörte Hamann; Charles A B Boucher; Jan C C Borleffs
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study).
AIDS (London, England) 1999;13(7):F53-8.
1999: Agnes I Veldkamp; Rolf P G van Heeswijk; Richard Hoetelmans; Pieter L Meenhorst; Jan W Mulder; Joep M A Lange; Jos H Beijnen
Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection.
Journal of chromatography. B, Biomedical sciences and applications 1999;727(1-2):151-7.
1999: NA Foudraine; Egbert Hovenkamp; Daan W Notermans; Pieter L Meenhorst; Michel Klein; Joep M A Lange; Frank Miedema; Peter Reiss
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.
AIDS (London, England) 1999;13(2):177-84.
1999: VR Nannan Panday; Richard Hoetelmans; Rolf P G van Heeswijk; Pieter L Meenhorst; M Inghels; Jan W Mulder; Jos H Beijnen
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study.
Cancer chemotherapy and pharmacology 1999;43(6):516-9.
1998: Richard Hoetelmans; Rolf P G van Heeswijk; M Profijt; Jan W Mulder; Pieter L Meenhorst; Joep M A Lange; Peter Reiss; Jos H Beijnen
Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individuals.
AIDS (London, England) 1998;12(17):F211-6.
1998: Richard Hoetelmans; M Profijt; Pieter L Meenhorst; Jan W Mulder; Rolf P G van Heeswijk; Jos H Beijnen
Co-trimoxazole and stavudine interference in a high-performance liquid chromatographic analysis for didanosine in human plasma.
Therapeutic drug monitoring 1998;20(6):669-72.
1998: Rolf P G van Heeswijk; Richard Hoetelmans; Remko Harms; Pieter L Meenhorst; Jan W Mulder; Joep M A Lange; Jos H Beijnen
Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography. B, Biomedical sciences and applications 1998;719(1-2):159-68.
1998: Rolf P G van Heeswijk; Richard Hoetelmans; Pieter L Meenhorst; Jan W Mulder; Jos H Beijnen
Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography. B, Biomedical sciences and applications 1998;713(2):395-9.
1998: Alwin D R Huitema; Marcel Soesan; Pieter L Meenhorst; Cornelis H W Koks; Jos H Beijnen
A dose-dependent delayed hypersensitivity reaction to acetaminophen after repeated acetaminophen intoxications.
Human & experimental toxicology 1998;17(7):406-8.
1998: Richard Hoetelmans; M van Essenberg; M Profijt; Pieter L Meenhorst; Jan W Mulder; Jos H Beijnen
High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva.
Journal of chromatography. B, Biomedical sciences and applications 1998;705(1):119-26.
1998: Daan W Notermans; Suzanne Jurriaans; Frank de Wolf; NA Foudraine; JJ de Jong; W Cavert; CM Schuwirth; Robbert H Kauffmann; Pieter L Meenhorst; H McDade; C Goodwin; J M Leonard; Jaap Goudsmit; Sven A Danner
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
AIDS (London, England) 1998;12(2):167-73.
1998: David Burger; Richard Hoetelmans; Patricia W H Hugen; Jan W Mulder; Pieter L Meenhorst; Peter P Koopmans; Kees Brinkman; M Keuter; Wil M V Dolmans; Yechiel A Hekster
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy.
Antiviral therapy 1998;3(4):215-20.
1998: S Ramcharan; Pieter L Meenhorst; J M Otten; Cornelis H W Koks; Douwe de Boer; Robert A A Maes; J H Beijnen
Survival after massive ecstasy overdose.
Journal of toxicology. Clinical toxicology 1998;36(7):727-31.
1998: NA Foudraine; Gerrit Jan Weverling; T van Gool; Marijke Th L Roos; Frank de Wolf; Peter P Koopmans; Peterhans J Van den Broek; Pieter L Meenhorst; Remko van Leeuwen; Joep M A Lange; Peter Reiss
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy.
AIDS (London, England) 1998;12(1):35-41.
1997: Richard Hoetelmans; M van Essenberg; Pieter L Meenhorst; Jan W Mulder; J H Beijnen
Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography. B, Biomedical sciences and applications 1997;698(1-2):235-41.
1997: Richard Hoetelmans; Pieter L Meenhorst; Jan W Mulder; David Burger; Cornelis H W Koks; Jos H Beijnen
Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir.
Pharmacy world & science : PWS 1997;19(4):159-75.
1997: David Burger; Richard Hoetelmans; Peter P Koopmans; Pieter L Meenhorst; Jan W Mulder; Yechiel A Hekster; J H Beijnen
Clinically relevant drug interactions with antiretroviral agents.
Antiviral therapy 1997;2(3):149-65.
1997: Richard Hoetelmans; C L Kraaijeveld; Pieter L Meenhorst; Jan W Mulder; David Burger; Cornelis H W Koks; J H Beijnen
Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(2):131-6.
1997: David Burger; C A Boucher; Pieter L Meenhorst; C L Kraayeveld; Peter Portegies; Jan W Mulder; Richard Hoetelmans; J H Beijnen
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
Antiviral therapy 1997;2(2):113-7.
1996: Cornelis H W Koks; Pieter L Meenhorst; M J Hillebrand; A Bult; Jos H Beijnen
Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules.
Antimicrobial agents and chemotherapy 1996;40(8):1935-7.
1996: Richard Hoetelmans; David Burger; Pieter L Meenhorst; Jos H Beijnen
Pharmacokinetic individualisation of zidovudine therapy. Current state of pharmacokinetic-pharmacodynamic relationships.
Clinical pharmacokinetics 1996;30(4):314-27.
1995: David Burger; C L Kraayeveld; Pieter L Meenhorst; Jan W Mulder; Richard Hoetelmans; Cornelis H W Koks; Jos H Beijnen
Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complex.
Pharmacy world & science : PWS 1995;17(6):218-21.
1995: David Burger; Pieter L Meenhorst; J Mulder; J Henrichs; J Frissen; F Kroon; C ten Napel; K Koks; A Bult; Jos H Beijnen
Substitution of didanosine sachets by chewable tablets: a pharmacokinetic study in patients with AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(2):163-8.
1995: F G Delemarre; A Stevenhagen; Frank P Kroon; M Y van Eer; Pieter L Meenhorst; Ralph van Furth
Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2.
AIDS (London, England) 1995;9(5):441-5.
1995: David Burger; Pieter L Meenhorst; Jos H Beijnen
Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents.
Pharmacy world & science : PWS 1995;17(2):25-30.
1995: Cornelis H W Koks; Hilde Rosing; Pieter L Meenhorst; A Bult; Jos H Beijnen
High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients.
Journal of chromatography. B, Biomedical applications 1995;663(2):345-51.
1995: P J M Bakker; Sven A Danner; C H ten Napel; Frank P Kroon; Herman Sprenger; R van Leusen; Pieter L Meenhorst; A Muusers; Cindy Veenhof
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF).
European journal of cancer (Oxford, England : 1990) 1995;31A(2):188-92.
1994: David Burger; Pieter L Meenhorst; C H ten Napel; Jan W Mulder; C Neef; Cornelis H W Koks; A Bult; Jos H Beijnen
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions.
AIDS (London, England) 1994;8(12):1683-9.
1994: David Burger; Pieter L Meenhorst; Jan W Mulder; C L Kraaijeveld; Cornelis H W Koks; A Bult; Jos H Beijnen
Therapeutic drug monitoring of phenytoin in patients with the acquired immunodeficiency syndrome.
Therapeutic drug monitoring 1994;16(6):616-20.
1994: F G Delemarre; A Stevenhagen; Frank P Kroon; M Y van Eer; Pieter L Meenhorst; Ralph van Furth
Effect of IFN-gamma on the proliferation of Toxoplasma gondii in monocytes and monocyte-derived macrophages from AIDS patients.
Immunology 1994;83(4):646-50.
1994: David Burger; Hilde Rosing; C H ten Napel; T Duyts; Pieter L Meenhorst; Jan W Mulder; Cornelis H W Koks; A Bult; Jos H Beijnen
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid.
Antimicrobial agents and chemotherapy 1994;38(12):2763-7.
1994: David Burger; Pieter L Meenhorst; Willy J M Underberg; J F van der Heijde; Cornelis H W Koks; J H Beijnen
Short-term, combined use of paracetamol and zidovudine does not alter the pharmacokinetics of either drug.
The Netherlands journal of medicine 1994;44(5):161-5.
1994: David Burger; Pieter L Meenhorst; Cornelis H W Koks; Jos H Beijnen
Pharmacokinetics of zidovudine and acetaminophen in a patient on chronic acetaminophen therapy.
The Annals of pharmacotherapy 1994;28(3):327-30.
1993: David Burger; C L Kraaijeveld; Pieter L Meenhorst; Jan W Mulder; Cornelis H W Koks; A Bult; Jos H Beijnen
Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV.
AIDS (London, England) 1993;7(12):1581-7.
1993: David Burger; Pieter L Meenhorst; Cornelis H W Koks; Jos H Beijnen
Pharmacokinetic interaction between rifampin and zidovudine.
Antimicrobial agents and chemotherapy 1993;37(7):1426-31.
1993: O Bekers; Jos H Beijnen; M J Tank; David Burger; Pieter L Meenhorst; A J Lombarts; Willy J M Underberg
2',3'-dideoxyinosine (ddI): its chemical stability and cyclodextrin complexation in aqueous media.
Journal of pharmaceutical and biomedical analysis 1993;11(6):489-93.
1993: W J Keijer; David Burger; G H Neuteboom; J L Vrooland; Pieter L Meenhorst; Cornelis H W Koks; Jos H Beijnen
Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Pharmacy world & science : PWS 1993;15(2):56-67.
1993: David Burger; Pieter L Meenhorst; Cornelis H W Koks; J H Beijnen
Drug interactions with zidovudine.
AIDS (London, England) 1993;7(4):445-60.
1992: David Burger; Hilde Rosing; R van Gijn; Pieter L Meenhorst; Olaf van Tellingen; Jos H Beijnen
Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography 1992;584(2):239-47.
1992: R M Franssen; Pieter L Meenhorst; Cornelis H W Koks; Jos H Beijnen
Didanosine, a new antiretroviral drug. A review.
Pharmaceutisch weekblad. Scientific edition 1992;14(5):297-304.
1992: O Pos; A Stevenhagen; Pieter L Meenhorst; Frank P Kroon; Ralph van Furth
Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients.
Clinical and experimental immunology 1992;88(1):23-8.
1991: Jos H Beijnen; Pieter L Meenhorst; R van Gijn; M Fromme; Hilde Rosing; Willy J M Underberg
HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients.
Journal of pharmaceutical and biomedical analysis 1991;9(10-12):995-1002.
1991: Jos H Beijnen; Pieter L Meenhorst; R van Gijn; W A Hazelager; Cornelis H W Koks; Willy J M Underberg
Gas chromatographic analysis, with electron capture detection, of the antifungal drug fluconazole in microvolumes of human plasma.
Journal of pharmaceutical and biomedical analysis 1991;9(10-12):1173-5.
1988: T L van Zwet; Pieter L Meenhorst; P C Leijh; M R Daha; Ralph van Furth
Characteristics of anti-Legionella antibodies in patients infected with Legionella pneumophila serogroups 1, 6, and 10.
Journal of clinical microbiology 1988;26(11):2377-81.
1987: M J Twisk-Meijssen; Pieter L Meenhorst; B J van Cronenburg; J D Mulder; E Scheffer; Ralph van Furth
The course of Legionella pneumonia in guinea pigs after inhalation of various quantities of L. pneumophila.
Immunobiology 1987;176(1-2):108-24.
1985: Pieter L Meenhorst; A L Reingold; D G Groothuis; G W Gorman; H W Wilkinson; R M McKinney; J C Feeley; D J Brenner; R van Furth
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10.
The Journal of infectious diseases 1985;152(2):356-64.
1983: Paul Herbrink; Pieter L Meenhorst; D G Groothuis; H V Munckhof; R Bax; C J Meijer; J Lindeman
Detection of antibodies against Legionella pneumophila serogroups 1 to 6 and the Leiden-1 strain by micro ELISA and immunofluorescence assay.
Journal of clinical pathology 1983;36(11):1246-52.
1983: Pieter L Meenhorst; J D Mulder
The chest X-ray in Legionella Pneumonia (Legionnaires' disease).
European journal of radiology 1983;3(3):180-6.
1983: Pieter L Meenhorst; B J van Cronenburg; Ralph van Furth
[The significance of tap water contaminated with Legionella pneumophila for the occurrence of Legionella pneumonia as hospital infection].
Nederlands tijdschrift voor geneeskunde 1983;127(8):327-32.
1983: Pieter L Meenhorst; A L Reingold; G W Gorman; J C Feeley; B J van Cronenburg; C L Meyer; Ralph van Furth
Legionella pneumonia in guinea pigs exposed to aerosols of concentrated potable water from a hospital with nosocomial Legionnaires' disease.
The Journal of infectious diseases 1983;147(1):129-32.